5-Fluoro-2-Oxindole CAS 56341-41-4 daahirnimo>99.0% (LCMS) Sunitinib Malate Warshada Dhexe
Shanghai Ruifu Chemical Co., Ltd. waa soo saaraha iyo soo saaraha 5-Fluoro-2-Oxindole (CAS: 56341-41-4) oo leh tayo sare leh, wax soo saarka ganacsiga.Ku soo dhawoow dalabka
Magaca Kiimikada | 5-Fluoro-2-Oxindole |
La mid ah | 5-Fluorooxindole;5-Fluoro-2-indolinone;5-Fluoroindolin-2-hal;5-Fluoro-1,3-Dihydro-indol-2-hal |
Lambarka CAS | 56341-41-4 |
Lambarka CAT | RF-PI1543 |
Heerka Saamiyada | Kaydka dhexdiisa, Qiyaasta Waxsoosaarka Ilaa Tan |
Qaanuunka molecular | C8H6FNO |
Miisaanka Molecular | 151.14 |
Cufnaanta | 1.311± 0.06 g/cm3 |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Budada Crystalline Jaallaha fudud |
1 H NMR Spectrum | Waafaqsan Qaab-dhismeedka |
LCMS | Waafaqsan Qaab-dhismeedka |
Daahirnimada / Habka Falanqaynta | >99.0% (LCMS) |
Meesha dhalaalaysa | 143.0 ~ 147.0 ℃ |
Khasaare xagga qalajinta | <0.50% |
Wadarta wasakhda | <1.00% |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Dhexdhexaadiyeyaasha Dawooyinka;Sunitinib Malate Dhexdhexaadiye |
Xidhmada: Dhalo, bacda bireed ee aluminium, 25kg / Durbaan kartoonada, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka.
5-Fluoro-2-Oxindole (CAS: 56341-41-4) waxaa inta badan loo adeegsadaa warshadaha dawooyinka sida dhexdhexaadka dawooyinka.5-Fluoro-2-Oxindole waa dhex dhexaad u ah isku dhafka Sunitinib Malate (CAS: 341031-54-7).Sunitinib Malate waa nooc cusub oo afka laga qaato oo lala beegsado dawooyinka kansarka oo badan waxaana iska leh tyrosine kinase inhibitor-bartilmaameedyo badan leh oo magaceeda ganacsi uu yahay “Suntent”.Waxaa si guul leh u soo saartay Shirkadda Pfizer waxayna leedahay saameyn laba geesood ah oo ka hortagga burooyinka.Waxaa intaa dheer, waa daawada kaliya ee daawaynta taas oo ka gudbi karta muddada 2-sano ee badbaadada kansarka kelyaha ee sare u kacday waxayna ka ciyaartaa doorka dhexe ee duurka kansarka iyo goobaha daaweynta burooyinka stromal stromal.Waxay soo gashay suuqa bishii Febraayo 2006 gudaha Mareykanka.Daawadani waxay ahayd daawadii ugu horaysay ee ka hortagga kansarka taas oo ay ansixisay US FDA oo isku mar dawayn karta laba cudur.